Exploring Syndecan-4 and MLP and Their Interaction in Primary Cardiomyocytes and H9c2 Cells

Thea Parsberg Støle1, Marianne Lunde1,2, Katja Gehmlich3,4

  • 1Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, 0450 Oslo, Norway.

Cells
|June 19, 2024
PubMed

Insights

Syndecan-4 binds to MLP in heart cells, but this interaction is disrupted by mutations linked to cardiomyopathy. MLP mutations also alter its self-association, potentially causing heart disease.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Cell Signaling

Background:

  • Syndecan-4 (a transmembrane proteoglycan) is implicated in the heart's hypertrophic response to pressure overload.
  • MLP (Muscle LIM Protein) mutations are found in human hypertrophic (HCM) and dilated cardiomyopathy (DCM).
  • MLP has been identified as a binding partner to syndecan-4's cytoplasmic tail.

Purpose of the Study:

  • To investigate the syndecan-4-MLP interaction in primary adult rat cardiomyocytes and H9c2 cells.
  • To understand the role of this interaction in MLP-associated cardiomyopathy.
  • To examine how MLP mutations affect its interaction with syndecan-4 and its oligomerization.

Main Methods:

  • Immunoprecipitation to analyze syndecan-4 and MLP binding in cell lysates and subcellular fractions.
  • Confocal microscopy for visualizing MLP and syndecan-4 localization.
  • ELISA and peptide arrays to study syndecan-4-MLP binding and MLP self-association.
  • Immunoblotting under native conditions to assess MLP oligomerization.

Main Results:

  • Syndecan-4 and MLP co-localized in various cellular compartments, with binding detected specifically in nuclear-enriched fractions of adult cardiomyocytes.
  • In vitro, syndecan-4 bound to MLP at three sites, with reduced binding observed for some HCM-associated MLP mutations.
  • MLP mutations altered MLP oligomerization, increasing monomers at the expense of trimers and tetramers, and affected MLP self-association sites.

Conclusions:

  • The syndecan-4-MLP interaction occurs in nuclear-enriched fractions of adult cardiomyocytes and is disrupted by certain HCM-associated MLP mutations.
  • MLP mutations impact its oligomerization and self-association, suggesting a critical mechanism in MLP-associated cardiomyopathy.
  • Further research into the syndecan-4-MLP interaction and MLP's structural changes is warranted for understanding cardiomyopathy pathogenesis.

Related Concept Videos